Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Weighted Average) (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $15.0 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $15.0 million, changed 0.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.0 million (changed 0.12% YoY), and the FY2025 annual result was $14.9 million, up 5.65% from the prior year.
• Shares Outstanding (Weighted Average) came in at $15.0 million for Q1 2026 at Cumberland Pharmaceuticals, up from $14.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $15.0 million in Q2 2025 to a low of $14.1 million in Q4 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $14.6 million (2022), against an average of $14.5 million.
• Across the five-year window, Shares Outstanding (Weighted Average) slipped 2.34% in 2023 and rose 6.17% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $14.6 million in 2022, then declined by 1.82% to $14.3 million in 2023, then declined by 1.67% to $14.1 million in 2024, then advanced by 5.65% to $14.9 million in 2025, then advanced by 0.71% to $15.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $15.0 million (Q1 2026), $14.9 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.